These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 24857631

  • 21. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
    Le S, Gruner JA, Mathiasen JR, Marino MJ, Schaffhauser H.
    J Pharmacol Exp Ther; 2008 Jun; 325(3):902-9. PubMed ID: 18305012
    [Abstract] [Full Text] [Related]

  • 22. Visualization of the activation of the histamine H3 receptor (H3R) using novel fluorescence resonance energy transfer biosensors and their potential application to the study of H3R pharmacology.
    Liu Y, Zeng H, Pediani JD, Ward RJ, Chen LY, Wu N, Ma L, Tang M, Yang Y, An S, Guo XX, Hao Q, Xu TR.
    FEBS J; 2018 Jun; 285(12):2319-2336. PubMed ID: 29701013
    [Abstract] [Full Text] [Related]

  • 23. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
    Gao Z, Hurst WJ, Guillot E, Czechtizky W, Lukasczyk U, Nagorny R, Pruniaux MP, Schwink L, Sanchez JA, Stengelin S, Tang L, Winkler I, Hendrix JA, George PG.
    Bioorg Med Chem Lett; 2013 Jun 01; 23(11):3416-20. PubMed ID: 23591110
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Design, synthesis, and biological evaluation of novel iso-flavones derivatives as H3R antagonists.
    Xin J, Hu M, Liu Q, Zhang TT, Wang DM, Wu S.
    J Enzyme Inhib Med Chem; 2018 Dec 01; 33(1):1545-1553. PubMed ID: 30293461
    [Abstract] [Full Text] [Related]

  • 26. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA.
    J Pharmacol Exp Ther; 2003 Jun 01; 305(3):887-96. PubMed ID: 12606603
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands.
    Kuder KJ, Łażewska D, Kaleta M, Latacz G, Kottke T, Olejarz A, Karcz T, Fruziński A, Szczepańska K, Karolak-Wojciechowska J, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2017 May 15; 25(10):2701-2712. PubMed ID: 28372935
    [Abstract] [Full Text] [Related]

  • 28. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H3 Receptor.
    Rosier N, Grätz L, Schihada H, Möller J, Işbilir A, Humphrys LJ, Nagl M, Seibel U, Lohse MJ, Pockes S.
    J Med Chem; 2021 Aug 12; 64(15):11695-11708. PubMed ID: 34309390
    [Abstract] [Full Text] [Related]

  • 29. Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists.
    Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Middekadi VR, Bogaraju N, Ravella SR, Singh P, Birangal SR, Subramanian R, Palacharla RC, Benade V, Muddana N, Jayarajan P.
    J Med Chem; 2018 Jun 14; 61(11):4993-5008. PubMed ID: 29763304
    [Abstract] [Full Text] [Related]

  • 30. Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones.
    Hua Y, Song M, Guo Q, Luo Y, Deng X, Huang Y.
    Molecules; 2023 Apr 12; 28(8):. PubMed ID: 37110645
    [Abstract] [Full Text] [Related]

  • 31. Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy.
    Gao Z, Hurst WJ, Hall D, Hartung R, Reynolds W, Kang J, Nagorny R, Hendrix JA, George PG.
    Bioorg Med Chem; 2015 Feb 01; 23(3):429-38. PubMed ID: 25577710
    [Abstract] [Full Text] [Related]

  • 32. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
    Célanire S, Wijtmans M, Christophe B, Collart P, de Esch I, Dassesse D, Delaunoy C, Denonne F, Durieu V, Gelens E, Gillard M, Lallemand B, Lamberty Y, Lebon F, Nicolas JM, Quéré L, Snip E, Vanbellinghen A, Van Houtvin N, Verbois V, Timmerman H, Talaga P, Leurs R, Provins L.
    ChemMedChem; 2009 Jul 01; 4(7):1063-8. PubMed ID: 19405064
    [Abstract] [Full Text] [Related]

  • 33. Identification of N-phenyl-3-methoxy-4-pyridinones as orally bioavailable H3 receptor antagonists and β-amyloid aggregation inhibitors for the treatment of Alzheimer's disease.
    Zhang M, Tang L, Jiang L, Wei J, Hu Y, Sheng R.
    Eur J Med Chem; 2021 Feb 15; 212():113096. PubMed ID: 33395621
    [Abstract] [Full Text] [Related]

  • 34. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
    Incerti M, Flammini L, Saccani F, Morini G, Comini M, Coruzzi M, Barocelli E, Ballabeni V, Bertoni S.
    ChemMedChem; 2010 Jul 05; 5(7):1143-9. PubMed ID: 20512794
    [Abstract] [Full Text] [Related]

  • 35. The evolution of histamine H₃ antagonists/inverse agonists.
    Lebois EP, Jones CK, Lindsley CW.
    Curr Top Med Chem; 2011 Jul 05; 11(6):648-60. PubMed ID: 21261594
    [Abstract] [Full Text] [Related]

  • 36. Novel naphthyloxy derivatives - Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation.
    Łażewska D, Kaleta M, Hagenow S, Mogilski S, Latacz G, Karcz T, Lubelska A, Honkisz E, Handzlik J, Reiner D, Satała G, Filipek B, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2018 May 15; 26(9):2573-2585. PubMed ID: 29681486
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety.
    Song M, Yan R, Zhang Y, Guo D, Zhou N, Deng X.
    J Enzyme Inhib Med Chem; 2020 Dec 15; 35(1):1310-1321. PubMed ID: 32529860
    [Abstract] [Full Text] [Related]

  • 38. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.
    von Coburg Y, Kottke T, Weizel L, Ligneau X, Stark H.
    Bioorg Med Chem Lett; 2009 Jan 15; 19(2):538-42. PubMed ID: 19091563
    [Abstract] [Full Text] [Related]

  • 39. Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors.
    Davenas E, Rouleau A, Morisset S, Arrang JM.
    J Pharmacol Exp Ther; 2008 Aug 15; 326(2):406-13. PubMed ID: 18474684
    [Abstract] [Full Text] [Related]

  • 40. Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson's Disease.
    Hagenow S, Affini A, Pioli EY, Hinz S, Zhao Y, Porras G, Namasivayam V, Müller CE, Lin JS, Bezard E, Stark H.
    J Med Chem; 2021 Jun 24; 64(12):8246-8262. PubMed ID: 34107215
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.